Outcome Measurement in Global Fund-supported Adolescent Girls and Young Women (AGYW) Programmes

The Global Fund Strategy 2017–2022, “Investing to End Epidemics”, has committed to scale-up HIV prevention programmes, to support adolescent girls and young women (AGYW) in 13 focus countries in Sub-Saharan Africa.

The goal is to reduce new HIV infections among adolescent girls and young women aged 15-24 by 58% by addressing the behavioral, biological, and structural factors driving HIV acquisition and transmission by and to AGYW. PHDA and the University of Manitoba are measuring outcomes of the Global Fund-supported AGYW programmes implemented in Malawi, Lesotho, Namibia, Cameroon, and Botswana.

Objectives

  • Implement a rapid, simple, cost-effective, efficient, easy to administer approach and innovative method to gather sexual, behavioral and structural outcomes of AGYW programmes within a programme set up and not a research setting;
  • Design a method for collecting sexual, behavioral, and structural outcomes. This will include the development of tools, data collection, and analysis
  • Build the capacity of programme staff of SRs (sub-recipients) and an identified local organization so that it can replicate this approach to collect outcome indicators regularly.

The outcome assessment will use the mixed-method approach for data collection. For the quantitative assessment, we will conduct “Polling Booth Surveys’’: a group interview method which has been used by the PHDA and the UM to measure sexual, behavioral and structural outcomes among key populations, adolescent girls, young women and the general population in several African and Asian countries.

Additionally, we will conduct “in-depth interviews or focus group discussions” with programme staff to develop an understanding of the programme package for the AGYW and understand factors leading to certain trends in outcomes.

Project Initiated 2020

Project Initiated 2020.

Partnerships

University of Manitoba. The project is funded by the Global Fund for Tuberculosis, Malaria, and HIV (GFATM). PHDA will also partner with the Principal Recipients of Global Fund in the 5 countries to implement the assessment.